Abstract
Severe loss of cerebral blood flow causes hypoxia and glucose deprivation in the brain tissue, resulting in necrotic cell death in the ischemic brain. Several endogenous molecules, called alarmins or damage-associated molecular patterns (DAMPs), are extracellularly released from the dead cells to activate pattern recognition receptors (PRRs) in immune cells that infiltrate into ischemic brain tissue following the disruption of the blood–brain barrier (BBB) after stroke onset. The activated immune cells produce various inflammatory cytokines and chemokines, triggering sterile cerebral inflammation in the ischemic brain that causes further neuronal cell death. Poststroke inflammation is resolved within several days after stroke onset, and neurological functions are restored to some extent as neural repair occurs around peri-infarct neurons. Clearance of DAMPs from the injured brain is necessary for the resolution of poststroke inflammation. Neurons and glial cells also express PRRs and receive DAMP signaling. Although the role of PRRs in neural cells in the ischemic brain has not yet been clarified, the signaling pathway is likely to be contribute to stroke pathology and neural repair after ischemic stroke. This review describes the molecular dynamics, signaling pathways, and functions of DAMPs in poststroke inflammation and its resolution.
Similar content being viewed by others
References
Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19(1):24–32. https://doi.org/10.1016/j.smim.2006.12.004
World Health Organization (2020) The top 10 cause of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Dreier JP, Reiffurth C (2015) The stroke-migraine depolarization continuum. Neuron 86(4):902–922. https://doi.org/10.1016/j.neuron.2015.04.004
Lai TW, Zhang S, Wang YT (2014) Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol 115:157–188. https://doi.org/10.1016/j.pneurobio.2013.11.006
Yang JL, Mukda S, Chen SD (2018) Diverse roles of mitochondria in ischemic stroke. Redox Biol 16:263–275. https://doi.org/10.1016/j.redox.2018.03.002
Neumann J et al (2015) Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. Acta Neuropathol 129(2):259–277. https://doi.org/10.1007/s00401-014-1355-2
Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17(4):359–365. https://doi.org/10.1016/j.coi.2005.06.002
Harris HE, Raucci A (2006) Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 7(8):774–778. https://doi.org/10.1038/sj.embor.7400759
Yang D, Han Z, Oppenheim JJ (2017) Alarmins and immunity. Immunol Rev 280(1):41–56. https://doi.org/10.1111/imr.12577
Kim JB et al (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26(24):6413–6421. https://doi.org/10.1523/JNEUROSCI.3815-05.2006
Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28(5):927–938. https://doi.org/10.1038/sj.jcbfm.9600582
Zhang J et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42(5):1420–1428. https://doi.org/10.1161/STROKEAHA
Yang QW et al (2011) HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 31(2):593–605. https://doi.org/10.1038/jcbfm.2010.129
Yanai et al (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462(7269):99–103. https://doi.org/10.1038/nature08512
Xiong XX, Gu LJ, Shen J, Kang XH, Zheng YY, Yue SB, Zhu SM (2014) Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice. Neurochem Res 39(1):216–224. https://doi.org/10.1007/s11064-013-1212-z
Goldstein RS et al (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25(6):571–574. https://doi.org/10.1097/01.shk.0000209540.99176.72
Huang JM, Hu J, Ning C, Hu ML (2013) Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke. J Crit Care 28(5):792–797. https://doi.org/10.1016/j.jcrc.2012.10.003
Schulze J, Zierath D, Tanzi P, Cain K, Shibata D, Dressel A, Becker K (2013) Severe stroke induces long-lasting alterations of high-mobility group box 1. Stroke 44(1):246–248. https://doi.org/10.1161/STROKEAHA.112.676072
Sapojnikova N, Kartvelishvili T, Asatiani N, Zinkevich V, Kalandadze I, Gugutsidze D, Shakarishvili R (1842) Tsiskaridze A (2014) Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome. Biochim Biophys Acta 9:1379–1384. https://doi.org/10.1016/j.bbadis.2014.04.031
Wang J, Jiang Y, Zeng D, Zhou W, Hong X (2020) Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis. J Stroke Cerebrovasc Dis 29(9):105055. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105055
Rashidian J et al (2009) Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J Neurosci 29(40):12497–12505. https://doi.org/10.1523/JNEUROSCI.3892-09.2009
Shichita T et al (2012) Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med 18(6):911–917. https://doi.org/10.1038/nm.2749
Kuang X (2014) Ligustilide ameliorates neuroinflammation and brain injury in focal cerebral ischemia/reperfusion rats: involvement of inhibition of TLR4/peroxiredoxin 6 signaling. Free Radic Biol Med 71:165–175. https://doi.org/10.1016/j.freeradbiomed.2014.03.028
Nakamura K et al (2021) Extracellular DJ-1 induces sterile inflammation in the ischemic brain. PLoS Biol 19(5):e3000939. https://doi.org/10.1371/journal.pbio.3000939
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) HumanTH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173–1175. https://doi.org/10.1038/nm1651
Richard S, Lapierre V, Girerd N, Bonnerot M, Burkhard PR, Lagerstedt L, Bracard S, Debouverie M, Turck N, Sanchez JC (2016) Diagnostic performance of peroxiredoxin 1 to determine time- of-onset of acute cerebral infarction. Sci Rep 6:38300. https://doi.org/10.1038/srep38300
Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA, Tardif MR, Cesaro A, Bose S (2014) DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation dur- ing influenza a virus infection: role of DDX21-TRIF-TLR4- MyD88 pathway. PLoS Pathog 10(1):e1003848. https://doi.org/10.1371/journal.ppat.1003848
Loser K et al (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the develop- ment of autoreactive CD8+ T cells. Nat Med 16(6):713–717. https://doi.org/10.1038/nm.2150
Vogl T et al (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13(9):1042–1049. https://doi.org/10.1038/nm1638
Qiang X et al (2013) Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat Med 19(11):1489–1495. https://doi.org/10.1038/nm.3368
Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrançois L, Li Z (2007) Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26(2):215–226. https://doi.org/10.1016/j.immuni.2006.12.005
Ekaney ML et al (2014) Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 18(5):543. https://doi.org/10.1186/s13054-014-0543-8
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373–384. https://doi.org/10.1038/ni.1863
Zhang Q, RaoofM CY, Sumi Y, Sursal T, JungerW BK, Itagaki K, Hauser CJ (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104–107. https://doi.org/10.1038/nature08780
Oka T et al (2012) Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485(7397):251–255. https://doi.org/10.1038/nature10992
Walko TD 3rd, Bola RA, Hong JD, Au AK, Bell MJ, Kochanek PM, Clark RS, Aneja RK (2014) Cerebrospinal fluid mitochon- drial DNA: a novel DAMP in pediatric traumatic brain injury. Shock 41(6):499–503. https://doi.org/10.1097/SHK.0000000000000160
Hyakkoku K et al (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171(1):258–267. https://doi.org/10.1016/j.neuroscience.2010.08.054
Brea D, Sobrino T, Rodríguez-Yáñez M, Ramos-Cabrer P, Agulla J, Rodríguez-González R, Campos F, Blanco M, Castillo J (2011) Toll- like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke. Clin Immunol 139(2):193–198. https://doi.org/10.1016/j.clim.2011.02.001
Gao D, Wu J, Wu Y-T, Du F, Aroh C, Yan N, Sun L, Chen ZJ (2013) Cyclic GMP- AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341(6148):903–906. https://doi.org/10.1126/science.1240933
Cai X, Chiu Y-H, Chen ZJ (2014) The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 54(2):289–296. https://doi.org/10.1016/j.molcel.2014.03.040
Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nat Immunol 17(10):1142–1149. https://doi.org/10.1038/ni.3558
Xia P, Wang S, Gao P, Gao G, Fan Z (2016) DNA sensor cGAS-mediated immune recognition. Protein Cell 7(11):777–791. https://doi.org/10.1007/s13238-016-0320-3
AblasserA S-B, HemmerlingI HGL, Schmidt T, Latz E, Hornung V (2013) Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503(7477):530–534. https://doi.org/10.1038/nature12640
Li Q, Cao Y, Dang C, Han B, Han R, Ma H, Hao J, Wang L (2020) Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke. EMBO Mol Med 12(4):e11002. https://doi.org/10.15252/emmm.201911002
Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K, Kohsaka S (2007) Involvement of P2X4 and P2Y12 receptors in ATP- induced microglial chemotaxis. Glia 55(6):604–616. https://doi.org/10.1002/glia.20489
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8(6):752–758. https://doi.org/10.1038/nn1472
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing ofproIL- β. Mol Cell 10(2):417–426. https://doi.org/10.1016/S1097-2765(02)00599-3
Verma R, Cronin CG, Hudobenko J, Venna VR, McCullough LD, Liang BT (2017) Deletion ofthe P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke. Brain Behav Immun 66:302–312. https://doi.org/10.1016/j.bbi.2017.07.155
Webster CM, Hokari M, McManus A, Tang XN, Ma H, Kacimi R, Yenari MA (2013) Microglial P2Y12 deficiency/inhibition protects against brain ischemia. PLoS ONE 8(8):e70927. https://doi.org/10.1371/journal.pone.0070927
Stewart CR et al (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11(2):155–161. https://doi.org/10.1038/ni.1836
Uchida K (2013) Redox-derived damage-associated molecular patterns: ligand function of lipid peroxidation adducts. Redox Biol 1(1):94–96. https://doi.org/10.1016/j.redox.2012.12.005
Gao S, Zhang R, Greenberg ME, Sun M, Chen X, Levison BS, Salomon RG, Hazen SL (2006) Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo. J Biol Chem 281(42):31298–31308. https://doi.org/10.1074/jbc.M604039200
Haider L, Fischer MT, Frishcer JM, Bauer J, Höftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134(Pt 7):1914–1924. https://doi.org/10.1093/brain/awr12
Ho PP et al (2012) Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci Transl Med 4(137):137ra73. https://doi.org/10.1126/scitranslmed.3003831
Miller YI et al (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 108(2):235–248. https://doi.org/10.1161/CIRCRESAHA.110.223875
Matt U et al (2013) WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J Clin Invest 123(7):3014–3024. https://doi.org/10.1172/JCI60681
Cho S, Park EM, Febbraio M, Anrather J, Park L, Racchumi G, Silverstein R, Iadecola C (2005) The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J Neurosci 25(10):2504–2512. https://doi.org/10.1523/JNEUROSCI.0035-05.2005
Abe T, Shimamura M, Jackman K, Kurinami H, Anrather J, Zhou P, Iadecola C (2010) Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke 41(5):898–904. https://doi.org/10.1161/STROKEAHA.109.572552
West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, Byzova TV (2010) Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467(7318):972–976. https://doi.org/10.1038/nature09421
Clemens JA, Stephenson DT, Smalstig EB, Roberts EF, Johnstone EM, Sharp JD, Little SP, Kramer RL (1996) Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke 27(3):527–535. https://doi.org/10.1161/01.STR.27.3.527
Bonventre JV, Huang Z, Taheri MR, O’Leary E, Li E, Moskowitz MA, Sapirstein A (1997) Reduced fertility and post ischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390(6660):622–625. https://doi.org/10.1038/37635
Muralikrishna Adibhatla R, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free RadicvBiol Med 40(3):376–387. https://doi.org/10.1016/j.freeradbiomed.2005.08.044
Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP (2013) The resolution of inflammation. Nat Rev Immunol 13(1):59–66. https://doi.org/10.1038/nri3362
Zera KA, Buckwalter M (2020) The local and peripheral immune responses to stroke: implications for therapeutic development. Neurotherapeutics 17(2):414–435. https://doi.org/10.1007/s13311-020-00844-3
Yu H, Cai Y, Zhong A, Zhang Y, Zhang J, Xu S (2021) The “dialogue” between central and peripheral immunity after ischemic stroke: focus on spleen. Front Immunol 12:792522. https://doi.org/10.3389/fimmu.2021.792522
Liu F, Cheng X, Zhong S, Liu C, Jolkkonen J, Zhang X, Liang Y, Liu Z, Zhao C (2020) Communications between peripheral and the brain-resident immune system in neuronal regeneration after stroke. Front Immnol 11:1931. https://doi.org/10.3389/fimmu.2020.01931
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extra- cellular traps kill bacteria. Science 303(5663):1532–1535. https://doi.org/10.1126/science.1092385
Parker H, Albrett AM, Kettle AJ, Winterbourn CC (2012) Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence ofhydrogen peroxide. J Leukoc Biol 91(3):369–376. https://doi.org/10.1189/jlb.0711387
Wu X, Zeng H, Cai L, Chen G (2021) Role of the extracellular traps in central nervous system. Front Immunol 12:783882. https://doi.org/10.3389/fimmu.2021.783882
Perez-de-Puig I, Miró-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C, Urra X, Chamorro A, Planas AM (2015) Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol 129(2):239–257. https://doi.org/10.1007/s00401-014-1381-0
Jorch SK, Kubes P (2017) An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med 23(3):279–287. https://doi.org/10.1038/nm.4294
Wang R et al (2021) Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke. Blood 138(1):91–103. https://doi.org/10.1182/blood.2020008913
Laridan E, Denorme F, Desender L, Francois O, Andersson T, Deckmyn H, Vanhoorelbeke K, De Meyer SF (2017) Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol 82(2):223–232. https://doi.org/10.1002/ana.24993
Pertiwi KR, de Boer OJ, Mackaaij C, Pabittei DR, de Winter RJ, Li X, van der Wal AC (2019) Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time-dependent manner during atherothrombosis. J Pathol 247(4):505–512. https://doi.org/10.1002/path.5212
Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391–397. https://doi.org/10.1016/S0166-2236(99)01401-0
Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796–808. https://doi.org/10.1038/nm.2399
Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cyto- kines in experimental and human stroke. J Cereb Blood Flow Metab 32(9):1677–2169. https://doi.org/10.1038/jcbfm.2012.88
Wattananit S et al (2016) Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. J Neurosci 36(15):4182–4195. https://doi.org/10.1523/JNEUROSCI.4317-15.2016
Shichita T et al (2009) Pivotal role of cerebral interleukin-17- producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15(8):946–950. https://doi.org/10.1038/nm.1999
Smirkin A et al (2010) Iba1+/NG2+ macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 30(3):603–615. https://doi.org/10.1038/jcbfm.2009.233
Shichita T et al (2017) MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Nat Med 23(6):723–732. https://doi.org/10.1038/nm.4312
Iliff JJ et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl Med 4(147):147ra111. https://doi.org/10.1126/scitranslmed.3003748
Albargothy NJ, Johnston DA, MacGregor-Sharp M, Weller RO, Verma A, Hawkes CA, Carare RO (2018) Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol 136(1):136–152. https://doi.org/10.1007/s00401-018-1862-7
Lv T, Zhao B, Hu Q, Zhang X (2021) The glymphatic system: a novel therapeutic target for stroke treatment. Front Aging Neurosci 13:689098. https://doi.org/10.3389/fnagi.2021.689098
Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J (2015) The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85(4):703–709. https://doi.org/10.1016/j.neuron.2015.01.013
Pomeshchik Y, KidinI KP, Savchenko E, Jaronen M, Lehtonen S, Wojciechowski S, Kanninen K, Koistinaho J, Malm T (2015) Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain Behav Immun 44:68–81. https://doi.org/10.1016/j.bbi.2014.08.002
Luo Y, Zhou Y, Xiao W, Liang Z, Dai J, Weng X, Wu X (2015) Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Brain Res 1597:86–94. https://doi.org/10.1016/j.brainres.2014.12.005
Fu AKY et al (2016) IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A 113(19):E2705-2713. https://doi.org/10.1073/pnas.1604032113
Luheshi NM, Kovács KJ, Lopez-Castejon G, Brough D, Denes A (2011) Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localized to areas of focal neuronal loss and penumbral tissues. J Neuroinflammation 29(8):186. https://doi.org/10.1186/1742-2094-8-186
Yang Y et al (2017) ST2/IL-33-dependent microglial response limits acute ischemic brain injury. J Neurosci 37(18):4692–4704. https://doi.org/10.1523/JNEUROSCI.3233-16.2017
Ito M et al (2019) Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery. Nature 565(7738):246–250. https://doi.org/10.1038/s41586-018-0824-5
Chen H et al (2016) IL-10 Promotes neurite outgrowth and synapse formation in cultured cortical neurons after the oxygen-glucose deprivation via JAK1/STAT3 pathway. Sci Rep 6:30459. https://doi.org/10.1038/srep30459
Vainchtein ID et al (2018) Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science 359(6381):1269–1273. https://doi.org/10.1126/science.aal3589
Hayakawa K, Qiu J, Lo EH (2010) Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 1207:50–57. https://doi.org/10.1111/j.1749-6632.2010.05728.x
Passalacqua M, Atrone M, Picotti GB, Del Rio M, Sparatore B, Melloni E, Pontremoli S (1998) Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82(4):1021–1028. https://doi.org/10.1016/s0306-4522(97)00352-7
Schlueter C, Weber H, Meyer B, Rogalla P, Röser K, Hauke S, Bullerdiek J (2005) Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 166(4):1259–1263. https://doi.org/10.1016/S0002-9440(10)62344-9
Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275(51):40096–40105. https://doi.org/10.1074/jbc.M006993200
Okun E, Griffioen KJ, Mattson MP (2011) Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 34(5):269–281. https://doi.org/10.1016/j.tins.2011.02.005
McKimmie CS, Fazakerley JK (2005) In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J Neuroimmunol 169(1–2):116–125. https://doi.org/10.1016/j.jneuroim.2005.08.006
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175(7):4320–4330. https://doi.org/10.4049/jimmunol.175.7.4320
Gorina R, Font-Nieves M, Márquez-Kisinousky L, Santalucia T, Planas AM (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling MAPK, and Jak1/Stat1 pathways. Glia 59(2):242–255. https://doi.org/10.1002/glia.21094
Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T (2010) Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A 107(25):11555–11560. https://doi.org/10.1073/pnas.1006496107
Tang SC et al (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 104(34):13798–13803. https://doi.org/10.1073/pnas.0702553104
Cameron JS et al (2007) Toll-like receptor 3 is a potent negative regulator ofaxonal growth in mammals. J Neurosci 27(47):13033–13041. https://doi.org/10.1523/JNEUROSCI.4290-06.2007
MaY LJ, Chiu I, Wang Y, Sloane JA, Lü J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T (2006) Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 175(2):209–215. https://doi.org/10.1083/jcb.200606016
Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132(4):645–660. https://doi.org/10.1016/j.cell.2008.01.033
Kojima T, Hirota Y, Ema M, Takahashi S, Miyoshi I, Okano H, Sawamoto K (2010) Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cell 28(3):545–554. https://doi.org/10.1002/stem.306
Lathia JD et al (2008) Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci 28(51):13978–13984. https://doi.org/10.1523/JNEUROSCI.2140-08.2008
Okun E et al (2010) TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem 114(2):462–474. https://doi.org/10.1111/j.1471-4159.2010.06778.x
Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartzet M (2007) Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 9(9):1081–1088. https://doi.org/10.1038/ncb1629
Funding
This work was supported by the Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST, JP21gm1210010), the Japan Society for the Promotion of Science (JSPS) KAKENHI (21H02820, 21K06386), Takeda Science Foundation, and the Uehara Memorial Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is a contribution to the special issue on: Immunopathology of Stroke – Guest Editors: Arthur Liesz & Tim Magnus
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sakai, S., Shichita, T. Role of alarmins in poststroke inflammation and neuronal repair. Semin Immunopathol 45, 427–435 (2023). https://doi.org/10.1007/s00281-022-00961-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-022-00961-5